Ramius Advisors’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Ramius Advisors’s Portfolio ISLEW Stock Details ISLEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-307,359	Closed	-$10K	–	329
2022 Q2	$10K	Buy	+307,359	New	+$39.2K	0.01%	181
2022 Q1	–	Sell	-306,359	Closed	-$152K	–	344
2021 Q4	$152K	Buy	306,359 +69,210	+29%	+$38.2K	0.05%	191
2021 Q3	$130K	Sell	237,149 -46,520	-16%	-$30.4K	0.08%	123
2021 Q2	$199K	Buy	283,669 +118,942	+72%	+$70.3K	0.08%	158
2021 Q1	$77K	Buy	+164,727	New	+$78.8K	0.02%	289

Ramius Advisors's ISLEW Position: Q3 2022 in Review

Ramius Advisors sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 307,359 shares — an estimated $10K sold.

Ramius Advisors first reported a position in ISLEW in Q1 2021 and held it in 5 quarters. The position peaked at $199K in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

Ramius Advisors reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Ramius Advisors sold 307,359 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $10K.
Ramius Advisors first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 5 quarters.
Ramius Advisors's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $199K in Q2 2021.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Ramius Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.